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Abstract
Background: Patients with higher levels of fasting serum glucose have higher death rates from pancreatic cancer compared
to patients with lower levels of fasting serum glucose. However, the reasons have not been studied. The goal of the current
study was to examine the neural alterations in pancreatic cancer patients with hyperglycemia and to identify the
relationship between the neural alterations and perineural invasion.
Methodology/Principal Findings: The clinical and pathological features of 61 formalin-fixed pancreatic cancer specimens
and 10 normal pancreases as controls were analyzed. Furthermore, the expression of Protein Gene Product 9.5 (PGP9.5),
Myelin P0 protein (MPP), NGF, TrkA, and p75 were examined by immunohistochemistry. The median number of nerves, the
median area of neural tissue, and the median nerve diameter per 10 mm
2 were larger in the hyperglycemia group than
those in the euglycemia group (p=0.007, p=0.009, and p=0.004, respectively). The integrated optical density (IOD) of MPP
staining was lower in the hyperglycemia group than those in the euglycemia group (p=0.019), while the expression levels
of NGF and p75 were higher in the hyperglycemia group than those in the euglycemia group (p=0.002, and p=0.026,
respectively). The nerve bundle invasion of pancreatic cancer was more frequent in the hyperglycemia group than in the
euglycemia group (p=0.000).
Conclusions/Significance: Nerve damage and regeneration occur simultaneously in the tumor microenvironment of
pancreatic cancer patients with hyperglycemia; the simultaneous occurrence may aggravate the process of perineural
invasion. The abnormal expression of NGF and p75 may also be involved in this process and subsequently lead to a lower
rate of curative surgery.
Citation: Li J, Ma Q, Liu H, Guo K, Li F, et al. (2011) Relationship between Neural Alteration and Perineural Invasion in Pancreatic Cancer Patients with
Hyperglycemia. PLoS ONE 6(2): e17385. doi:10.1371/journal.pone.0017385
Editor: John Minna, Univesity of Texas Southwestern Medical Center at Dallas, United States of America
Received October 6, 2010; Accepted February 1, 2011; Published February 28, 2011
Copyright:  2011 Li et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study was supported by the National Natural Scientific Foundation of China (2009 No. 30900705) and a Scientific Grant from Xi’an City (2009
No. GG06718) (Q. Ma), and partially by ND EPSCoR (E. Wu). The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: qyma56@ mail.xjtu.edu.cn (QM); erxi.wu@ndsu.edu (EW)
Introduction
Pancreatic cancer (PanCa) is a fatal disease with almost 100%
mortality rate. Although surgery is effective in 20% of patients, the
tendency for local recurrence in the retroperitoneum has not been
fully understood [1]. One of the main causes of local recurrence of
the tumor is perineural invasion (PNI) [2], which is frequently
found in PanCa (as high as 90%–100%) [3,4]. As a common but
nonspecific feature of PanCa [5], PNI is an important prognostic
factor in PanCa. Also, PNI increases as the cancer becomes
undifferentiated (i.e. MIA PaCa-2 PanCa cells) in PanCa [6].
Because the pancreas is an organ with rich innervations
originating from the superior mesenteric plexus and the celiac
plexus, we need to pay attention to both the extrapancreatic
perineural invasion (with infiltration into one or more extra-
pancreatic neural plexuses) and the intrapancreatic perineural
invasion [7]. It has been suggested that the perineurium (the
sheath of connective tissue enclosing a bundle of nerve fibers)
blocks neural invasion of PanCa. However, perineurium damage
has been identified at the end of the nerve, at the site where the
nerve is invaded by the blood vessels around nerves, and at the site
invaded by reticular fibers [8]. As a result, PanCa cells easily
invade from the weakened areas of the perineurium to the
perineural space. If systemic or local factors continue to erode the
strength of the perineurium, the extent of perineural invasion may
be high.
Furthermore, the simultaneous appearance of PanCa and
diabetes mellitus (DM) has long been recognized. Long standing
DM increases the likelihood for PanCa to a moderate extent [9];
in most cases, however, new onset DM is one of the first clinical
signs of PanCa [10,11]. DM is an independent predictor of
mortality from cancer of the pancreas [12]. Approximately 80% of
PanCa patients have glucose intolerance or frank diabetes [13,14].
In Korea, both elevated fasting serum glucose levels and a
PLoS ONE | www.plosone.org 1 February 2011 | Volume 6 | Issue 2 | e17385diagnosis of diabetes are regarded as independent risk factors for
several major cancers, including stomach cancer, liver cancer, lung
cancer, and PanCa; and the risk of these conditions increase with an
increased level of fasting serum glucose [15]. In addition, the
Korean patients with the highest fasting serum glucose had higher
death rates from all cancers combined such as cancers of esophagus,
larynx, stomach, colon, liver, bile duct, pancreas, lung, prostate,
kidney, bladder, and brain as well as leukemia compared to the
patients with the lowest level of fasting serum glucose [15]. Among
these cancer types, the association between the death rates and
fasting serum glucose levels was strongest for PanCa in men and in
women [15,16]. Also, neuronal glucose uptake depends on the
extracellular concentration of glucose. Hyperglycemia in diabetes
can cause up to four-fold increases in neuronal glucose levels. If the
persistent episodes of hyperglycemia exist, then intracellular glucose
metabolism leads to neuronal damage [17]. Such damages can lead
to several debilitating problems since neuropathy frequently results
in clinically significant morbidities, such as pain, loss of sensation,
foot ulcer, gangrene, and amputation [18,19].
Even though PNI and hyperglycemia are common phenomena in
PanCa, research has not determined if the two factors generate a
synergistic effect to promote the progression of PanCa. Recent
studies [2] have demonstrated that PNI may be involved in
reciprocal signaling interactions between tumor cells and nerves,
and that theinvadingtumorcellsmayrespond topre-invasivesignals
within the peripheral nerve milieu. To examine the effect of
hyperglycemia on the nerve tissue in PanCa, we analyzed the
functional and morphological changes of nerves in the tumors of
PanCa patients with and without hyperglycemia, and then we
examined the relationship between the changes and PNI. In order to
investigate themorphological featuresofthe nervesinthe newtumor
microenvironment, Protein Gene Product 9.5 (PGP9.5) and Myelin
P0protein(MPP)werelabeled withinthenervefibersand themyelin
sheaths, by using immunohistochemical methods. Therefore, a
better understanding of the hyperglycemia-nerve relationship may
shed new light on the mechanisms of PNI in PanCa.
Methods
Ethical Permission
The study protocol and consent forms conform to the
Declaration of Helsinki and were approved by the Ethical Review
Board (ERB) Committee (The First Affiliated Hospital of Medical
College, Xi’an Jiaotong University, China) and informed consent
was obtained from all subjects.
Patients
From January 1999 to March 2008, 513 pancreatic tumors were
subjected to clinical examinationat the FirstAffiliated Hospital, Xi’an
Jiaotong University, China. Among them, 420 cases were pancreatic
ductal carcinoma excluding intraductal papillary mucinous tumor,
acinar cell carcinoma, and islet cell carcinoma. Ultimately, sixty-one
patients who received a radical curative pancreatic operation with a
pathologic diagnosis were investigated in this study. The median
patient age was 58 years, and 22 of the patients were female. None of
the patients received neo-adjuvant therapy before their initial
operation. Regional lymph node dissection was performed in all
patients, and portal vein resections were performed in 17 patients.
None of the 61 patients received an adjuvant treatment.
Grouping and clinical parameters
The 420 pancreatic tumors were divided into two groups
according to the fasting blood glucose levels (an average level of
long term for the patients with the history of DM and an average
level of three days continuous after hospitalization) of the patients:
(1) euglycemia/normal and (2) hyperglycemia/high. As summa-
rized in Table 1, four clinical parameters were evaluated in each
group, including: (1) abdominal pain, (2) curative operation, (3)
history of DM, and (4) radiating pain. Of the patients with a history
of DM, the cases were divided into a controlled group and an
uncontrolled group (the level of blood glucose was not controlled to
normal) according to the fasting blood glucose levels. Three clinical
parameters were evaluated in each group, including: (1) abdominal
pain, (2) curative operation, and (3) radiating pain.
Quantitative analysis of neural tissue
An analysis of pancreatic nerves was carried out by two
independent researchers with the aid of digital image analysis and
the Image Pro-plus software (Media Cybernetics, Maryland, USA).
A charge coupled device (CCD) video camera and PROSCAN
electronics 5000 (Hama, Germany) connected to the Image Pro-
plus version 6.0 software (Media Cybernetics) were used to measure
the entire area of each tissue section, number of nerves, and the
nerve area. From the recorded measurements, the average area of
nerves per 10 mm
2 tissue areas and the percentage of tissue invaded
by nerves were calculated. The innervation area per nerve and
number of nerves per 10 mm
2 of tissue area were also calculated.
Immunohistochemistry
Immunohistochemical stainings were performed on 3 mm
sections of the formalin-fixed paraffin-embedded samples using a
standard avidin-biotin complex peroxidase technique. After
deparaffinization with xylene and rehydration with serial gradient
ethanol, the antigen was retrieved by heating the slides in 10 mM
of citrate buffer (pH 6.0) for 6 min in a microwave. The
endogenous peroxidase was blocked with 0.3% hydrogen
peroxide. The slides were subsequently incubated with a blocking
protein (Dako, CA, USA) for 10 min and primary antibody was
added overnight at 4uC followed by rinsing. The antibodies used
were: monoclonal anti-Protein Gene Product 9.5 (PGP9.5,
Table 1. Comparison of clinical parameters in the different groups of pancreatic cancer (%).
Parameters Abdominal pain Radiating pain History of diabetes Curative operation
Euglycemia group 75.28(201/267) 28.84(77/267) 3.75(10/267) 16.86(45/267)
Hyperglycemia group 74.51(114/153) 30.72(47/153) 24.18(37/153)* 10.46(16/153)
Controlled group 80.00(8/10) 30.00(3/10) 10.00(1/10)
Uncontrolled group 56.76(21/37) * 21.62(8/37) 2.70(1/37) *
Chi-square test was performed to compare the clinical feature.
*, Hyperglycemia group versus Euglycemia group and Uncontrolled group versus Controlled group: P,0.05, respectively.
doi:10.1371/journal.pone.0017385.t001
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China), polyclonal anti-Myelin P0 protein (MPP, Beijing Biosyn-
thesis Biotechnology Co., LTD, Beijing, China), polyclonal anti-
nerve growth factor (NGF) (Millipore, MA, USA), polyclonal anti-
TrkA (Cell Signaling Technology, Inc., MA, USA) and polyclonal
anti-p75 (Sigma, MO, USA). The secondary biotinylated goat
anti-rabbit antibody or goat anti-mouse antibody (Dako) was then
applied for 30 min, followed by 30 min of incubation with
streptavidin peroxidase (Dako LSAB+ HRP kit). After rinsing, the
slides were visualized by diaminobenzidine (DAB) chromogen
solution (Dako) and counterstained with routine hematoxylin,
followed by dehydration through graded ethanol and mounting of
the slides. The control group was selected from ten normal
pancreatic tissues from euglycemic patients with normal body
mass indices and whose ages had been matched with the
experimental groups. To ensure the specificity of the primary
antibodies, consecutive tissue sections were incubated in the
absence of the primary antibody. No immunostaining was
detected in these sections, showing the specificity of the primary
antibodies used in this study.
Histological examination and criteria for PNI evaluation
The resected specimens were fixed in 10% formalin at room
temperature, and the size and gross appearance of the tumors
were recorded. Each tumor was sectioned at intervals of 0.5 to
0.7 cm, and all of the sections were routinely processed and
embedded in paraffin for histological examination. Serial sections
(4 mm) of each tumor were processed. Then, the sections, stained
with hematoxylin and eosin, were examined pathologically to
confirm the diagnosis and assessed for tumor invasion of nerves.
The protocol for evaluating the degree of PNI was modified from a
previously described method [20]. The degree of PNI was
classified into four grades as follows according to the new
definition of PNI [21]: Ne0–no perineural invasion; Ne1–neurium
invasion; Ne2–perineural space invasion; Ne3–nerve bundle
invasion. Protocols for the study were approved by the ERB
Committee for Human Research of Xi’an Jiaotong University.
Two investigators assessed the histological parameters and
classified the degree of PNI. Whenever a discrepancy occurred,
both investigators re-examined the slides to reach a consensus.
Statistical analysis
Statistical analysis was performed with the SPSS 17.0
statistical program. Data were given as means 6 standard
deviation (S.D.). For statistical analysis, the Student- Newman-
Keuls (SNK) test, one-way analysis of variance, and Chi-square
tests were used. A p value less than 0.05 was considered
significant.
Results
The effect of blood glucose on clinical parameters
Of all 420 cases, 153 (36.43%) had hyperglycemia, including
new-onset diabetes and uncontrolled diabetes. The rest (267 cases)
in the euglycemia group included no diabetic or controlled
diabetic cases. As shown in Table 1, the hyperglycemia group had
a lower frequency of abdominal pain, curative operation, and
higher frequency of radiating pain. However, these differences
were not statistically significant. Among the 153 hyperglycemia
cases, 37 had a history of diabetes, compared with 10 of 267
euglycemia cases (p=0.000, Chi-square test), and these differences
were statistically significant. According to the fasting blood glucose
levels, the cases with the history of diabetes were divided into the
controlled or uncontrolled groups. The frequencies of abdominal
pain and curative operation were significant lower in the
uncontrolled group than that in euglycemia group (p=0.017 and
p=0.025, respectively, Chi-Square test). The degree of radiating
pain was not significant different between the two groups
(p=0.359, Chi-Square test).
Comparison of neural changes between euglycemia
group and hyperglycemia group
The immunostaining of the neuron specific protein PGP9.5 was
localized to the nerve fibers of pancreatic tissues (Fig. 1). The
number of immunostainings represents the number and area of
pancreatic nerve. The immunostaining of MPP which guides the
wrapping process and ultimately compacts adjacent lamellae, was
localized to the membrane of Schwann cells (Fig. 2). MPP
expression in the nerves was significantly lower (p=0.019) in the
hyperglycemia group than in the euglycemia group, indicating
Figure 1. Nerve tissue immunostaining in different group. PGP 9.5 immunostaining in the normal pancreas (A, D, arrowhead), pancreatic
cancer in euglycemia group (B, E, arrowhead), and hyperglycemia group (C, F, arrowhead). A, B, C show an original magnification of 1006, and D, E, F
an original magnification of 2006. In the hyperglycemia group, comparable increases in the number, area, and diameter of nerve tissues were
present. Figure arrowheads indicate the immunostainings.
doi:10.1371/journal.pone.0017385.g001
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Table 2, the median area and median number of nerves per
10 mm
2 of tissue area were significantly higher in the hypergly-
cemia group than in the euglycemia group (p=0.007, p=0.009,
respectively). The median nerve area and median nerve diameter
(p=0.004) were significantly higher in the hyperglycemia group
than in the euglycemia group.
In contrast, MPP expression in the nerves was significantly
lower in the uncontrolled group than in the controlled group. The
median area and median number of nerves per 10 mm
2 of tissue
area were also higher in the uncontrolled group than all other
groups. The median nerve area and median nerve diameter were
higher in the uncontrolled group than all other groups.
Thecytokines/growthfactorsexpressionindifferentgroups
The majority of cancer cells and nerve tissues showed distinct
immunostainings of TrkA, P75NTR, and NGF localized to the
cytoplasm. The nerve tissues had different expression levels of
TrkA and p75NTR by immunostaining between the euglycemia
group and hyperglycemia group. (Fig. 3). As shown in Fig. 4, the
NGF staining in the cytoplasm of the cancer cells was significantly
stronger (p=0.002) in the hyperglycemia group than in the
euglycemia group, indicating the NGF protein level of cancer cells
was increased in the hyperglycemia group. The percentage of
cancer area occupied by positive NGF staining cancer cells was
significantly higher in the hyperglycemia group than in the
euglycemia group. In the cross section of the nerves, the TrkA
immunostaining of nerve fibers was equivalent in the two groups
with no significant differences (p=0.626). The p75NTR immu-
nostaining had a peripheral pattern, where the surrounding area of
nerve fibers was strongly stained and the central area was mildly
stained in the hyperglycemia group; in contrast, the p75NTR
immunostaining in the euglycemia group was light and uniform
(p=0.026).
Figure 2. Myelin sheath immunostaining in different group. MPP immunostaining of pancreatic cancer tissue in the euglycemia group (A, B,
arrowhead) and hyperglycemia group (C, D, arrowhead). The left panel shows an original magnification of 1006, and the right panel an original
magnification of 4006. The frequency of moderate to strong MPP staining of nerves was significantly lower in the hyperglycemia group than in the
euglycemia group. Figure arrowheads indicate the immunostainings.
doi:10.1371/journal.pone.0017385.g002
Table 2. Comparison of nerve related parameters in the different groups.
Parameter MTA(mm
2) MNN MAN(mm
2) MND(mm)
Normal pancreas 86.9464.85 1.9360.13 1959.356184.87 32.7661.94
Euglycemia group 103.3267.57 2.0660.19 2002.386126.34 33.1962.95
Hyperglycemia group 124.6465.38 2.2460.25* 2279.986191.69* 35.9562.95*
Controlled group 109.23 2.2160.32 2257.366224.32 35.2361.87
Uncontrolled group 125.34 2.3160.38 2303.266217.16 36.3262.77
The Student- Newman-Keuls was performed to compare nerve related parameters in the different groups.
*, Hyperglycemia group versus Euglycemia group and Normal pancreas group. P,0.05, respectively.
MTA, Median tissue area analyzed (mm
2); MNN, Median No of nerves per 10 mm
2 tissue area; MAN, Median area of nerves per 10 mm
2 tissue area (mm
2); MND, Median
nerve diameter (mm).
doi:10.1371/journal.pone.0017385.t002
PNI Mechanisms in PanCa with Hyperglycemia
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Representative images of normal structures of the nerves and
the invading neural structure in various stages of classification in
pancreatic tissues are shown in Fig. 5. A nerve bundle surrounded
by the continuously layered epithelioid sheets is called the
perineurium, while the internal space between the nerve bundle
and perineurium is the perineural space. The degree of PNI was
classified into four grades according to the presence of cancer cells
in the different structures of the nerve tissues. As shown in Table 3,
the total frequency of PNI was higher in the hyperglycemia group
than that in the euglycemia group with no statistically significant
difference. However, the frequency of the Ne3 invasion was
significantly higher in the hyperglycemia group than that in the
euglycemia group (p=0.000, continuity correction).
Discussion
In the current study, we present the neural alteration and extent
of PNI in the primary tumors of PanCa patients in the context of
glucose control. Our data suggest that hyperglycemia, a common
confounding factor associated with PanCa, may contribute to PNI.
We demonstrated that patients with hyperglycemia display
reduced expression of MPP, and elevated expression of NGF
and p75 in comparison to the patients with euglycemia.
Furthermore, tumors from patients with hyperglycemia showed
an elevation in the stage of PNI in comparison to tumors from the
patients with euglycemia (Table 3).
Pain generation in PanCa seems to be multifactorial. It is
speculated that abdominal pain in PanCa patients results from the
invasion of cancer cells into neighboring organs [22]. Neuropathy
seems to be caused by intra- and extra-pancreatic perineural
invasion and damage to nerves by inflammatory and/or cancer
cells [6,23–25]. We did not find related studies about the
Figure 3. NGF, TrkA, and p75 immunostaining of pancreatic cancer tissue in the euglycemia group and hyperglycemia group. A, C, E,
G, I, K show an original magnification of 1006, and B, D, F, H, J, L an original magnification of 4006. The frequency of moderate to strong NGF
staining of cancer cells was significantly higher in the hyperglycemia group than that in the euglycemia group (arrowhead). The NGF stain of nerves
was not significantly different between the two groups. The moderate to strong TrkA stainings were also present in the two groups (arrowhead) but
with no significant difference. The frequency of moderate to strong p75 staining of nerves (arrowhead) was significantly higher in the hyperglycemia
group than that in the euglycemia group. Figure arrowheads indicate the immunostainings.
doi:10.1371/journal.pone.0017385.g003
Figure 4. The comparation of four parameters in different
group. Sixty-one patients who received a radical curative pancreatic
operations at the First Affiliated Hospital, Xi’an Jiaotong University with a
pathologic diagnose were investigated, which included 45 specimen in
euglycemia group and 16 specimen in hyperglycemia group. The MPP,
NGF, TrkA and p75 immunostainings were analyzed by Image-Pro Plus
software. The integrated optical density (IOD) of MPP staining was lower
inthe hyperglycemiagroup thanthat inthe euglycemiagroup(p=0.019).
The IOD of NGF and p75 stainings were higher in the hyperglycemia
group than that in the euglycemia group (p=0.002, p=0.026). The IOD of
TrkA staining was not significantly different between the two groups.
doi:10.1371/journal.pone.0017385.g004
PNI Mechanisms in PanCa with Hyperglycemia
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penetrate the perineurium and becomes intimately associated with
Schwann cells and axons in the endoneurium. The neural
remodeling shows how pancreatic neuropathic pain and visceral
neuropathy are associated with altered pancreatic innervation in
PanCa [26]. New data show that up to 80% of patients are either
hyperglycemic or diabetic, both of which can be detected in the
pre-symptomatic phase [14]. It is now recognized that impaired
glucose tolerance, even without overt DM, may be a risk factor for
the diabetic peripheral neuropathy (DPN). Neuropathic pain is a
prominent early feature of DPN and can be severe despite
minimal signs of DPN [27].
Accordingly, we reasoned that abdominal pain in PanCa
patients with the history of DM should occur more frequently than
those without the history of DM. In our study, the abdominal pain
was more frequent, in the euglycemia group compared with the
hyperglycemia group. The curative operation rate was significant-
ly higher in the euglycemia group compared with the hypergly-
cemia group, indicating that the history of DM is associated with
the lower curative operation rate in PanCa patients. With further
investigation, we found that in those patients with a history of DM,
the rates of abdominal pain and curative operation were
significantly lower in the group that the level of blood glucose
was uncontrolled to normal compared with the controlled group
(Table 1). We believe that this phenomenon is not easily explained
with a single theory because the microenvironment progressively
worsens in these patients. The destructive effect of the cancer cells
on nerves with compression is very mild, but the cancer can irritate
Figure 5. The classification of PNI in different group. Ne0–no perineural invasion; Ne1–neurium invasion; Ne2–perineural space invasion; Ne3–
nerve bundle invasion. The nerve structures (A, B) and representative stages of the invaded neural structure for classification (C–H). (A) A nerve
bundle surrounded by the continuous layered epithelioid sheets of the perineurium (arrowhead). (B) The perineural space, an internal space between
the nerve bundle and perineurium (arrowhead). (C) Neurium invasion of cancer cells in the outer perineural space and attached to the perineurium
(arrowhead). (D) Perineurial cells of perineurium between the nerve bundle and cancer cells (arrowhead). (E) Perineural space invasion of cancer cells
in the perineural space (arrowhead). (F) Cancer cells invading the perineural space and compressing the nerve bundle smoothly. The border between
cancer cells and nerve bundles do not contain perineurial cells or perineurium (arrowhead). (G) Nerve bundle invasion by cancer cells. Cancer cells
irregularly compress the nerve bundle, clearly invading between nerve fibers (arrowhead). (H) Invasive cancer cells clearly seen between nerve fibers
(arrowhead). A, C, E, G show an original magnification of 1006, and B, D, F, H an original magnification of 4006. Figure arrowheads indicate the
nerves.
doi:10.1371/journal.pone.0017385.g005
Table 3. The classification of perineural invasion in the two groups.
Parameter PNI (%) Ne0 Ne1 (%) Ne2 (%) Ne3 (%)
Euglycemia group 84.44(38/45) 7 68.42(26/38) 21.05(8/38) 10.53(4/38)
Hyperglycemia group 93.75(15/16) 1 13.33(2/15) 20.00(3/15) 66.67(10/15)
*
Controlled group 100(1/1) 0 0 0 100(1/1)
Uncontrolled group 100(1/1) 0 0 0 100(1/1)
One-way analysis of variance was performed to compare the classification of perineural invasion in the two groups.
*, Hyperglycemia group versus Euglycemia group: P,0.05.
doi:10.1371/journal.pone.0017385.t003
PNI Mechanisms in PanCa with Hyperglycemia
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were exposed in hyperglycemia state, hyperglycemia can exert a
strong destructive effect on the fragile nerves, which promotes the
progression from initial functional damage to late irreversible
structural damage with or without attenuated pain.
The main morphological features such as a combination of
demyelinization (damage to the myeline sheath of neurons), axonal
degeneration of myelinated fibers, and degeneration with
regeneration of unmyelinated fibers and endoneurial microangi-
opathy, with nerve fiber loss in its final stage, are present in the
established neuropathy [19]. We found that the MPP expression
level was lower in the hyperglycemia and blood glucose
uncontrolled groups, which indicated the dysfunction or demy-
elinization of the affected nerve sheaths. In addition, we observed
that the median number of nerves and median nerve diameters
were greater in the hyperglycemia and blood glucose uncontrolled
groups; this phenomenon suggests that nerve damage and repair
are simultaneous in the new environment.
It is known that the observations of abnormal NGF levels in
rodents and human diabetic nerves led to clinical trials to test the
efficacy of NGF as a therapeutic agent for deficient neurotrophins.
NGF treatment was shown to stimulate axon branching in the
footpad, suggesting that NGF treatment exerted biological effects
on cutaneous axons [28]. Our data demonstrated that NGF-
positive cancer cells were evident and coincident with the
improved nerves in the hyperglycemia group. We suggest that
hyperglycemia may induce the NGF expression of cancer cells,
which regenerates the affected nerves by stimulating axon
branching and that NGF may be as potential key player in the
generation of pancreatic neuropathy in PanCa [29]. Our
observation of increased staining of p75NTR in the hyperglycemia
group indicated dysfunction or demyelinization of the affected
nerve sheaths and was consistent with a previous report suggesting
that excessive NGF may cause apoptosis via p75NTR [30]. If
nerve degeneration exceeds nerve regeneration in pathological
conditions like DPN, nerve fiber loss may progress. However, if the
specific therapy could be found to decrease nerve degeneration
and/or increases nerve regeneration, pathological conditions,
including nerve fiber degeneration and loss, could be improved
[31].
In this study, we also found that the frequency and extent of
PNI were increased in the hyperglycemia group. Thus, the special
morphological features of affected nerves in the new microenvi-
ronment also may be correlated to the common phenomenon of
PNI. First, the nerves increase in number, which offers more
opportunities for cancer cells to invade and connect with the
superior mesenteric plexus and the celiac plexus. The possibility of
recurrence is increased even after curative operation. Second, the
regenerated axons and demyelination can form a low resistance
channel, which facilitates cancer cells to penetrate. When cancer
cells penetrate the nerve and grow in the endoneurium, they affect
the nerve processes and surrounding Schwann cells. Thus, all
elements of the nerve are subject to damage and to be functionally
altered. Furthermore, the cancer cells not only extend along the
long axis of the nerve, but also tend to grow around the
circumference, sometimes subsequently isolating the nerve from
the surrounding tissue. In this manner, DM aggravates the PanCa
prognosis by promoting PNI.
It should be noted that we have only analyzed the tumors from
patients with curative operation in both euglycemia and
hyperglycemia groups. We were not able to obtain suitable
specimens from non-curable patients for two reasons. In some
cases, the examination of the abdominal cavity during surgery
revealed extensive metastasis, so we could not treat the cancer. In
other cases, we could only perform palliative surgery such as
drainage for jaundice because the tumor could not be resected.
Despite these selections, our data showed that tumors from
hyperglycemic patients exhibit an elevation in the stage of PNI in
comparison to tumors from euglycemic patients (Table 3).
In summary, our results indicate that DM destroys pancreatic
nerves with a pattern of pathological axons regeneration and
demyelination in the tumor microenvironment, especially when
blood glucose is not controlled. The consequence of destroyed
nerves may aggravate a poor prognosis by two mechanisms: (1)
destroyed nerves hide the abdominal pain of PanCa and hinder
the early detection of PanCa and (2) destroyed nerves increase the
frequency and extent of PNI in PanCa, which is a risk factor for
local recurrence.
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